These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 17456683)
1. Amitriptyline is a potent blocker of human Kv1.1 and Kv7.2/7.3 channels. Punke MA; Friederich P Anesth Analg; 2007 May; 104(5):1256-64, tables of contents. PubMed ID: 17456683 [TBL] [Abstract][Full Text] [Related]
2. N-(6-chloro-pyridin-3-yl)-3,4-difluoro-benzamide (ICA-27243): a novel, selective KCNQ2/Q3 potassium channel activator. Wickenden AD; Krajewski JL; London B; Wagoner PK; Wilson WA; Clark S; Roeloffs R; McNaughton-Smith G; Rigdon GC Mol Pharmacol; 2008 Mar; 73(3):977-86. PubMed ID: 18089837 [TBL] [Abstract][Full Text] [Related]
3. Characterization of a novel Kv1.5 channel blocker in Xenopus oocytes, CHO cells, human and rat cardiomyocytes. Bachmann A; Gutcher I; Kopp K; Brendel J; Bosch RF; Busch AE; Gögelein H Naunyn Schmiedebergs Arch Pharmacol; 2001 Nov; 364(5):472-8. PubMed ID: 11692231 [TBL] [Abstract][Full Text] [Related]
4. Open channel block of A-type, kv4.3, and delayed rectifier K+ channels, Kv1.3 and Kv3.1, by sibutramine. Kim SE; Ahn HS; Choi BH; Jang HJ; Kim MJ; Rhie DJ; Yoon SH; Jo YH; Kim MS; Sung KW; Hahn SJ J Pharmacol Exp Ther; 2007 May; 321(2):753-62. PubMed ID: 17312186 [TBL] [Abstract][Full Text] [Related]
5. Lipophilic and stereospecific interactions of amino-amide local anesthetics with human Kv1.1 channels. Punke MA; Friederich P Anesthesiology; 2008 Nov; 109(5):895-904. PubMed ID: 18946303 [TBL] [Abstract][Full Text] [Related]
6. Novel, potent inhibitors of human Kv1.5 K+ channels and ultrarapidly activating delayed rectifier potassium current. Lagrutta A; Wang J; Fermini B; Salata JJ J Pharmacol Exp Ther; 2006 Jun; 317(3):1054-63. PubMed ID: 16522807 [TBL] [Abstract][Full Text] [Related]
7. The facilitating effect of systemic administration of Kv7/M channel blocker XE991 on LTP induction in the hippocampal CA1 area independent of muscarinic activation. Song MK; Cui YY; Zhang WW; Zhu L; Lu Y; Chen HZ Neurosci Lett; 2009 Sep; 461(1):25-9. PubMed ID: 19463897 [TBL] [Abstract][Full Text] [Related]
8. [Epileptic seizures from etomidate? The human Kv1.1 potassium channel in humans]. Friederich P; Trellakis S; Urban BW Anasthesiol Intensivmed Notfallmed Schmerzther; 2001 Feb; 36(2):100-4. PubMed ID: 11269011 [TBL] [Abstract][Full Text] [Related]
9. A possible link between KCNQ2- and STXBP1-related encephalopathies: STXBP1 reduces the inhibitory impact of syntaxin-1A on M current. Devaux J; Dhifallah S; De Maria M; Stuart-Lopez G; Becq H; Milh M; Molinari F; Aniksztejn L Epilepsia; 2017 Dec; 58(12):2073-2084. PubMed ID: 29067685 [TBL] [Abstract][Full Text] [Related]
10. Angiotensin II regulates neuronal excitability via phosphatidylinositol 4,5-bisphosphate-dependent modulation of Kv7 (M-type) K+ channels. Zaika O; Lara LS; Gamper N; Hilgemann DW; Jaffe DB; Shapiro MS J Physiol; 2006 Aug; 575(Pt 1):49-67. PubMed ID: 16777936 [TBL] [Abstract][Full Text] [Related]
11. Cinnamyl-3,4-dihydroxy-alpha-cyanocinnamate and nordihydroguaiaretic acid inhibit human Kv1.5 currents independently of lipoxygenase. Gong YZ; Ding WG; Wu J; Tsuji K; Horie M; Matsuura H Eur J Pharmacol; 2008 Dec; 600(1-3):18-25. PubMed ID: 18930721 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of the cloned delayed rectifier K+ channels, Kv1.5 and Kv3.1, by riluzole. Ahn HS; Choi JS; Choi BH; Kim MJ; Rhie DJ; Yoon SH; Jo YH; Kim MS; Sung KW; Hahn SJ Neuroscience; 2005; 133(4):1007-19. PubMed ID: 15964489 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of HERG channels by the local anaesthetic articaine. Siebrands CC; Friederich P Eur J Anaesthesiol; 2007 Feb; 24(2):148-53. PubMed ID: 16938156 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of Kv7/M Channel Currents by the Local Anesthetic Chloroprocaine. Zhang F; Cheng Y; Li H; Jia Q; Zhang H; Zhao S Pharmacology; 2015; 96(3-4):124-30. PubMed ID: 26202459 [TBL] [Abstract][Full Text] [Related]
16. Concatemers of brain Kv1 channel alpha subunits that give similar K+ currents yield pharmacologically distinguishable heteromers. Sokolov MV; Shamotienko O; Dhochartaigh SN; Sack JT; Dolly JO Neuropharmacology; 2007 Aug; 53(2):272-82. PubMed ID: 17637465 [TBL] [Abstract][Full Text] [Related]
17. Retigabine stimulates human KCNQ2/Q3 channels in the presence of bupivacaine. Punke MA; Friederich P Anesthesiology; 2004 Aug; 101(2):430-8. PubMed ID: 15277926 [TBL] [Abstract][Full Text] [Related]
18. Electrophysiological and pharmacological characterization of a novel and potent neuronal Kv7 channel opener SCR2682 for antiepilepsy. Zhang F; Liu Y; Tang F; Liang B; Chen H; Zhang H; Wang K FASEB J; 2019 Aug; 33(8):9154-9166. PubMed ID: 31063701 [TBL] [Abstract][Full Text] [Related]
19. Anxiolytic effects of Maxipost (BMS-204352) and retigabine via activation of neuronal Kv7 channels. Korsgaard MP; Hartz BP; Brown WD; Ahring PK; Strøbaek D; Mirza NR J Pharmacol Exp Ther; 2005 Jul; 314(1):282-92. PubMed ID: 15814569 [TBL] [Abstract][Full Text] [Related]
20. Suppression of KCNQ/M (Kv7) potassium channels in dorsal root ganglion neurons contributes to the development of bone cancer pain in a rat model. Zheng Q; Fang D; Liu M; Cai J; Wan Y; Han JS; Xing GG Pain; 2013 Mar; 154(3):434-448. PubMed ID: 23352759 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]